The liver cancer treatment team at Children's Mercy combines the medical and surgical expertise of the Division of Hematology and Oncology with the Liver Care Center. This program provides specialized services and research for treating pediatric patients with malignant liver tumors.
Our program provides specialized treatment for pediatric hepatoblastoma, the most common malignant liver tumor in the United States. Once patients complete treatment, the team continues to follow their progress through a quarterly liver tumor clinic.
Liver cancer treatment team
Our pediatric subspecialty team includes oncologists, hepatologists, and transplant surgeons, as well as support services offered through social work and nutrition. Our multidisciplinary staff collaborates to create the best care plans for our patients and provides ongoing support well after treatment is complete.
Through its affiliation with the Children's Oncology Group, Children's Mercy is researching chemotherapy regimens to determine which are more effective in pediatric patients with liver cancer.
Each year, the Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation at Children’s Mercy Kansas City provides comprehensive care to nearly 2,000 children with childhood cancers, sickle cell disease, hemophilia and other blood disorders, with survival rates frequently above national averages.
Our commitment to clinical research and innovation has helped us earn recognition as one of the top cancer programs for kids in the nation by U.S. News and World Report. Children’s Mercy also has received accreditation from the American College of Surgeons Commission on Cancer and the Foundation for Accreditation of Cellular Therapy.